Company | 3M Company |
Ticker | MMM US |
Reporting Period | Q2 2026 (quarter ending June 30, 2026) |
Earnings Date | July 21, 2026 — 9:00 AM ET |
Last Earnings | April 21, 2026 (Q1 2026) |
Prepared | July 20, 2026 |
Sector ETF Benchmark | XLI (Industrial Select Sector SPDR) |
Key Takeaway: The setup is modestly constructive — consensus is a beatable bar on organic growth and EPS, management has explicitly guided Q2 organic growth to be solidly above 3% (vs. the ~3.2% consensus), and the macro contingency embedded in full-year guidance has not been called upon. The single biggest swing factor is whether the strong order and backlog build converts cleanly to revenue, or whether any pre-buy pull-forward creates a Q3 air pocket.
Heading into the Q2 2026 print, the bar for 3M is achievable but not low. Consensus sits at ~$2.25 adjusted EPS and ~3.2% organic growth — both figures that management effectively pre-confirmed at the June 10 Wells Fargo conference, where CEO William Brown stated Q2 organic growth would be "solidly above 3%" and that orders and backlog had continued to build through June. The guidance posture has shifted meaningfully more confident since the Q1 call: management walked back its earlier pre-buy characterization, attributing sustained order strength to commercial excellence and innovation rather than channel stocking, and confirmed the $0.05–$0.15 EPS macro contingency is not expected to be needed. Estimate revisions have drifted modestly higher since the Q1 print — Q2 EPS consensus moved from ~$2.23 to ~$2.25 and organic growth from ~2.8% to ~3.2% — tracking directionally with management's more confident tone. The stock has recovered from its post-Q1 dip (down ~2% on April 21) and is roughly flat since last earnings, trading at ~17x NTM P/E, a multiple that prices in continued execution but not a step-change acceleration. The key wildcard is the data center / Expanded Beam Optics (EBO) ramp: management doubled its TAM estimate to north of $2 billion within 90 days of Q1 earnings and flagged that its capacity expansion may already be insufficient — any update on EBO order conversion and back-half delivery timing could be the most market-moving disclosure of the call.
Key Takeaway: Consensus is a beatable bar on both EPS (~$2.25) and organic growth (~3.2%), with management having pre-confirmed Q2 will be "solidly above 3%." The bigger swing factor is operating margin — management guided ~24.5% for Q2, which is above the ~24.6% consensus, leaving room for a modest upside surprise if volume flow-through is clean.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Guidance (Q1 Call) | Consensus vs. Guidance |
Net Sales ($B) | $6.03B | $6.34B | $6.31B | -0.5% YoY | ~3% organic growth implied | In line |
Adj. EPS - Diluted ($) | $2.14 | $2.16 | $2.25 | +4.2% YoY | Grow >$0.05 vs Q1; ~$2.19+ | +~$0.06 above floor |
Organic Growth - Operating (%) | 1.2% | 1.5% | 3.2% | +170 bps YoY | >3% ("solidly above 3%" per June conf.) | +~20 bps above floor |
Operating Margin - Operating (%) | 23.8% | 24.5% | 24.6% | +10 bps YoY | ~24.5% | +~10 bps above guidance |
Free Cash Flow - Operating ($B) | $0.54B | $1.28B | $1.05B | -18% YoY | >100% FCF conversion (FY) | N/A (FY metric) |
Sources: Visible Alpha Consensus and Actuals Data (Net Sales, EPS-Diluted Operating, Organic Growth Operating, Operating Margin Operating, Free Cash Flow Operating). Q1 2026 actuals and Q2 2025 actuals from Visible Alpha. Q2 2026 consensus as of July 20, 2026. Guidance from Q1 2026 earnings call (April 21, 2026) and Wells Fargo Industrials & Materials Conference (June 10, 2026).
Quarter | Reported ($) | Consensus ($) | Surprise % | Result |
Q1 2026 | $2.14 | $2.01 | +6.5% | Beat |
Q4 2025 | $1.83 | $1.79 | +2.2% | Beat |
Q3 2025 | $2.19 | $2.08 | +5.3% | Beat |
Q2 2025 | $2.16 | $2.01 | +7.5% | Beat |
Q1 2025 | $1.88 | $1.75 | +7.4% | Beat |
Q4 2024 | $1.68 | $1.63 | +3.1% | Beat |
Q3 2024 | $1.98 | $1.91 | +3.7% | Beat |
Q2 2024 | N/A — pre-Solventum spin | N/A | N/A | N/A |
Source: Visible Alpha Consensus and Actuals Data. Consensus figures represent the as-of-date consensus at the time of each print.
Quarter | Reported (%) | Consensus (%) | Surprise (bps) | Result |
Q1 2026 | 1.2% | 2.3% | -110 bps | Miss |
Q4 2025 | 2.2% | 2.5% | -30 bps | Miss |
Q3 2025 | 3.2% | 2.3% | +90 bps | Beat |
Q2 2025 | 1.5% | 2.0% | -50 bps | Miss |
Q1 2025 | 1.5% | 1.7% | -20 bps | Miss |
Q4 2024 | 2.1% | 1.5% | +60 bps | Beat |
Q3 2024 | 1.0% | 1.5% | -50 bps | Miss |
Q2 2024 | N/A — pre-Solventum spin | N/A | N/A | N/A |
Pattern: 3M has beaten adjusted EPS consensus in every quarter since the Solventum spin (7 for 7), typically by 3–8%, reflecting consistent productivity outperformance. Organic growth, however, has been a more mixed story — missing consensus in 5 of 7 quarters — making Q2's pre-confirmed "solidly above 3%" guidance particularly notable as a potential inflection. Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Full-year guidance is unchanged in range ($8.50–$8.70 adj. EPS, ~3% organic growth), but the tone has shifted materially more confident since the Q1 call. Management confirmed at the June 10 Wells Fargo conference that the $0.05–$0.15 macro contingency is not expected to be needed, and Q2 organic growth will be "solidly above 3%" — effectively a soft pre-announcement of a beat.
Metric | Initial Guidance (Q1 2026 Call, Apr 21) | Revised Guidance | Current Consensus | Note |
FY 2026 Adj. EPS | $8.50 – $8.70 | Unchanged | $8.75 | Consensus sits above guidance midpoint; management noted trending $0.05–$0.15 higher internally but held range due to macro contingency. At June 10 Wells Fargo conf., confirmed contingency not expected to be needed — tone more confident. |
FY 2026 Organic Growth | ~3% | Unchanged | ~2.97% | Consensus in line with guidance. Outgrowth vs. macro tracking to exceed $300M in 2026 (vs. $150M in 2025), ahead of 3-year $1B target schedule. |
Q2 2026 Organic Growth | >3% | "Solidly above 3%" (June 10 conf.) | ~3.2% | ↑ Strengthened at Wells Fargo June 10, 2026; management confirmed orders and backlog continued to build through June; pre-buy characterization from Q1 call walked back. |
Q2 2026 Adj. Operating Margin | ~24.5% | Unchanged | ~24.6% | Consensus marginally above guidance; management guided "solid margin, about 24.5%" on Q1 call. |
FY 2026 Adj. Operating Margin Expansion | +70 to +80 bps | Unchanged | ~24.1% | Business group margin expansion guided at ~100 bps; net productivity target at least halfway to $1B annualized by year-end 2026. |
FY 2026 Adj. Free Cash Flow | $4.6B – $4.8B (>100% conversion) | Unchanged | ~$4.74B | Consensus in line with guidance midpoint. |
FY 2026 Pricing | ~80 bps (original); updated to ~130 bps on Q1 call due to oil-driven cost pass-through | Unchanged at ~130 bps | N/A (not separately tracked in consensus) | Oil-based price increase of ~$125M / ~50 bps implemented May 1 in US/Europe; management confirmed at June conf. pricing governance improving. |
EBO / Data Center TAM | >$1B (stated at Q1 earnings, Apr 21) | Revised to >$2B (June 10 conf., ~90 days later) | N/A | ↑ Doubled TAM estimate at Wells Fargo June 10, 2026; capacity expansion announced earlier in year now viewed as potentially insufficient; first hyperscaler order placed in Q1 for back-half delivery. |
Key Takeaway: Estimates have drifted modestly higher since the Q1 print across all key metrics, tracking directionally with management's more confident tone. The gap between consensus EPS ($8.75) and guidance midpoint ($8.60) reflects the market pricing in that the macro contingency will not be needed — a view management itself endorsed at the June conference. Organic growth estimates have moved most meaningfully, rising ~46 bps for Q2 since the post-Q1 baseline, consistent with management's explicit upgrade to "solidly above 3%."
KPI (Period) | Estimate (Apr 28, 2026 — 5 days post-Q1) | Current Consensus (Jul 20, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Adj. EPS — Q2 2026 | $2.23 | $2.25 | +0.9% | >$2.19 (grow >$0.05 vs Q1 $2.14) | Unchanged | — | +~$0.06 above floor |
Adj. EPS — FY 2026 | $8.70 | $8.75 | +0.6% | $8.50 – $8.70 | Unchanged | — | +1.7% above midpoint ($8.60) |
Net Sales — Q2 2026 ($B) | $6.31B | $6.31B | Flat | ~3% organic growth implied | Unchanged | — | In line |
Net Sales — FY 2026 ($B) | $25.15B | $25.11B | -0.2% | ~4% total sales growth | Unchanged | — | In line |
Organic Growth — Q2 2026 (%) | 2.76% | 3.22% | +46 bps | >3% | "Solidly above 3%" (June 10 conf.) | ↑ Strengthened | +~20 bps above floor |
Organic Growth — FY 2026 (%) | 2.68% | 2.97% | +29 bps | ~3% | Unchanged | — | In line with guidance |
Adj. Operating Margin — Q2 2026 (%) | 24.57% | 24.56% | Flat | ~24.5% | Unchanged | — | +~10 bps above guidance |
Adj. Operating Margin — FY 2026 (%) | 24.05% | 24.10% | +5 bps | +70 to +80 bps expansion | Unchanged | — | In line |
Source: Visible Alpha Consensus and Actuals Data. Post-Q1 baseline uses consensus as of April 28, 2026 (5 trading days after April 21, 2026 earnings). Current consensus as of July 20, 2026. Guidance from Q1 2026 earnings call (April 21, 2026) and Wells Fargo Industrials & Materials Conference (June 10, 2026).
The most notable revision is in organic growth, where Q2 estimates have risen ~46 bps since the post-Q1 baseline, directly tracking management's explicit upgrade at the June conference. EPS revisions are modest (+0.6–0.9%) but directionally positive, and the consensus sitting above the guidance midpoint on FY EPS reflects the market's view that the macro contingency will not be called upon — a view management itself endorsed.
Key Takeaway: MMM is roughly flat since the Q1 earnings date (April 21, 2026), underperforming both XLI (+3.9%) and the S&P 500 (+5.4%) over the same period. The underperformance is primarily multiple compression — NTM EV/EBITDA has contracted from ~13.3x to ~12.0x over 6 months — as the market has not yet rewarded the transformation story with a re-rating, despite improving fundamentals. The stock's relative weakness since last earnings creates a lower bar for a positive reaction if Q2 delivers on the pre-confirmed organic growth acceleration.
Indexed Performance Since Last Earnings (Base = 100 at April 21, 2026 close):
Date | MMM (Indexed) | XLI (Indexed) | SPY (Indexed) |
Apr 21, 2026 (Last Earnings) | 100.0 | 100.0 | 100.0 |
Apr 30, 2026 | 98.7 | 101.8 | 102.1 |
May 18, 2026 (Australia PFAS lawsuit) | 102.7 | 99.6 | 104.9 |
Jun 10, 2026 (Wells Fargo Conference) | 105.6 | 99.0 | 103.0 |
Jun 24, 2026 (Post-conference peak) | 111.8 | 105.1 | 104.1 |
Jul 9, 2026 (NY PFAS lawsuit) | 104.6 | 105.7 | 106.8 |
Jul 21, 2026 (Earnings Day) | 107.2 | 103.9 | 105.4 |
Source: Yahoo Finance / Stock Price Data. MMM base price: $148.47 (Apr 21, 2026 close). XLI base: $171.44. SPY base: $704.08. Jul 21, 2026 prices: MMM $159.11, XLI $178.12, SPY $742.09.
Key Events Since Last Earnings:
Valuation Context: MMM trades at ~17.4x NTM P/E and ~12.0x NTM EV/EBITDA as of July 20, 2026. The NTM EV/EBITDA multiple has compressed from ~13.3x six months ago (-9.7%), meaning the stock's flat performance since last earnings has been driven by earnings growth partially offset by multiple contraction. The market is not yet awarding a transformation premium; a clean Q2 beat with raised guidance could catalyze re-rating.
Key Takeaway: The most important development since Q1 earnings is management's explicit upgrade of Q2 organic growth guidance to "solidly above 3%" at the June 10 Wells Fargo conference, effectively pre-confirming a beat. The second most important is the escalating PFAS litigation tail — two new major lawsuits (Australia and New York) filed since Q1 — which will likely dominate Q&A and weigh on sentiment regardless of operational results.
Key Takeaway: No open-market insider purchases or discretionary sales were identified for MMM in the period since the Q1 2026 earnings call (April 21, 2026) through July 20, 2026. The absence of insider buying is not a negative signal given the transformation narrative is well-established; the absence of discretionary selling is modestly constructive. No 10b5-1 plan initiations or Form 144 filings were identified for MMM in this window.
Name | Title | Transaction Type | Value | Date | Note |
No reportable open-market transactions identified for MMM in the Apr 21 – Jul 20, 2026 window. | — | — | — | — | No Form 4 open-market buys (code P) or discretionary sells (code S) found in SEC filings database for this period. |
Key Takeaway: Peer commentary from the last 60 days is broadly constructive for MMM's Q2 setup. Rockwell Automation and Honeywell both reported strong industrial demand, raised full-year guidance, and confirmed robust order trends — all positive read-throughs for 3M's Safety & Industrial and Transportation & Electronics segments. The semiconductor and data center end markets are the standout positives across all peers. The only cautionary note is Pentair's pool-segment inventory destocking, which has limited read-through to MMM's Consumer segment.
Note: Only commentary issued May 21 – July 20, 2026 that discusses the then-current Q2 2026 reporting quarter or forward outlook is included below. Retrospective prior-quarter commentary is excluded.
Relevance to MMM: High — ROK is the largest pure-play industrial automation company; its end-market commentary directly maps to MMM's Safety & Industrial and Transportation & Electronics segments.
Relevance to MMM: High — Honeywell is the closest large-cap diversified industrial peer; its building, process, and industrial automation commentary maps directly to MMM's Safety & Industrial segment.
Relevance to MMM: Moderate — GE Aerospace's aerospace aftermarket and engine demand commentary is a read-through for MMM's aerospace-exposed materials and components within T&E.
Relevance to MMM: Moderate — Cintas serves similar industrial and commercial end markets; its uniform/workwear demand is a proxy for industrial employment and activity levels.
Relevance to MMM: Low-to-moderate — Pentair's pool segment destocking is specific to residential/consumer end markets; limited direct read-through to MMM's industrial businesses, but relevant to MMM's Consumer segment.
Relevance to MMM: Moderate — Fastenal is a major industrial distributor; its results are a real-time read on industrial demand and channel inventory levels.
Peer | Commentary Date | Key Signal for MMM Q2 | Direction | Relevance |
Rockwell Automation (ROK) | Jun 2 & Jun 11, 2026 | Industrial demand broadening; semi/data center raised; no pre-buy; 7% FY guide raised; 250 bps pricing | Positive | High |
Honeywell (HON) | Jun 8, 2026 | Q2 on track; orders strongest in 6 years; IA short-cycle recovery; 4% pricing; Middle East impact manageable | Positive | High |
GE Aerospace (GE) | Jul 16, 2026 | Q2 EPS +8.6% beat; revenue +24%; bookings +17%; FCF +43%; FY guidance raised; aerospace demand robust | Positive | Moderate |
Cintas (CTAS) | Jul 15, 2026 | Revenue +8.9%; organic growth 8.3%; FY guidance above consensus; healthy industrial employment | Positive | Moderate |
Pentair (PNR) | Jul 14–15, 2026 | Pool segment destocking; Q2 sales -17% vs. consensus +1%; FY guide cut; CFO resigned | Cautionary | Low-Moderate (Consumer only) |
Fastenal (FAST) | Jul 14, 2026 | Gross margin pressure in industrial distribution channel | Cautionary | Moderate |